BetterLife Pharma (BETRF) Debt Ratio (2011 - 2026)

BetterLife Pharma has reported Debt Ratio for 16 years, with the latest figure at 7.17 in Q2 2026.

• On a quarterly basis, Debt Ratio fell 1.57% year-over-year to 7.17 in Q2 2026; TTM through Apr 2026 was 7.17, a 1.57% decrease from a year earlier, with the FY2026 full-year figure at 8.07, down 22.65% from the prior year.
• Debt Ratio was 7.17 for Q2 2026 at BetterLife Pharma, down from 8.07 in the prior quarter.
• The five-year high for Debt Ratio was 13.97 in Q1 2023, with the low at 0.97 in Q2 2023.
• Average Debt Ratio over 5 years is 4.57, with a median of 2.78 recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 1746.42% in 2022, then tumbled 66.06% in 2024.
• Over 5 years, Debt Ratio stood at 2.78 in 2022, then decreased by 26.6% to 2.04 in 2023, then jumped by 127.84% to 4.65 in 2024, then advanced by 17.79% to 5.47 in 2025, then jumped by 30.9% to 7.17 in 2026.
• The last three Debt Ratio figures came in at 7.17 (Q2 2026), 8.07 (Q1 2026), and 5.47 (Q3 2025), per Business Quant data.